Skip to content Skip to search Skip to footer
WashU Medicine

The DOLF Project

Death to Onchocerciasis and Lymphatic Filariasis

Menu
  • About DOLF
    • 15th Anniversary Symposium
    • Contact Us
  • Diseases
    • Lymphatic Filariasis (LF)
    • Onchocerciasis (Oncho)
    • Soil Transmitted Helminths (STH)
    • Loiasis (Loa loa)
  • Studies
    • Study Sites
    • Map of Study Sites
    • Annual vs Semiannual Community MDA Studies
    • Albendazole Only for LF Studies
    • Soil Transmitted Helminths (STH) Studies
    • IDA for LF Studies
    • IDA for Onchocerciasis Studies
    • Moxidectin for LF Studies
    • Diagnostic Methods
  • Our Team
    • Collaborating Institutions
    • Partnerships & Funders
    • Technical Advisory Team
    • Past Collaborators
  • Publications
  • News

Publications: IDA for Onchocerciasis Studies

Potential value of triple drug therapy with ivermectin, diethylcarbamazine, and albendazole (IDA) to accelerate elimination of lymphatic filariasis and onchocerciasis in Africa
Fischer PU, King CL, Jacobson JA, Weil GJ
PLoS Negl trop Dis. 2017;11(1):e0005

All DOLF Sponsored Publications

WashU Medicine Death to Onchocerciasis & Lymphatic Filariasis (DOLF) Project

MSC 3051-66-2212

660 South Euclid Avenue

St. Louis, MO 63110-1010

dolfproject@wustl.edu

Contact Us

  • Twitter

©2025 Washington University in St. Louis

Subscribe

Subscribe By Email

Get every new post delivered right to your inbox.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.